DrugDashboards

Potassium Chloride

Potassium Chloride · POTASSIUM CHLORIDE 600 mg/1 · Capsule, Extended Release · Oral · PD-Rx Pharmaceuticals, Inc.

NDC 72789-0056-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

19 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 70010-0147-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$0.2405per unit
middle half $0.1389$0.3403 · 5,438 plans · Apr 1, 2026
Est. net of rebates
≈ $0.2405
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
99%of plans cover it
tier 2 · prior auth 0% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 9 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for potassium chloride (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $24.12 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Xywav and Xyrem

Regulatory

Application
ANDA208864
TE code
AB
Approval date
Mar 17, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Potassium Chloride (Capsule, Extended Release)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
AvKAREPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
AvPAKPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USAPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Granules India LtdPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Granules India LtdPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Granules Pharmaceuticals IncPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Granules Pharmaceuticals IncPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
NCS HealthCare of KY, LLC dba Vangard LabsPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.POTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare LLCPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.POTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.POTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Potassium Chloride — NDC 72789-0056-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72789005601.

Free to cite with attribution — see how the data is put together.